Coformulation of Pembrolizumab and Vibostolimab in Patients (pts) with Docetaxel-Pretreated Metastatic Castration-Resistant Prostate Cancer (mcrpc): KEYNOTE-365 Cohort G.

Peter C. C. Fong,Mariusz Kwiatkowski,Alessandra Mosca,Begona Perez Valderrama, Yi-Hsiu Huang,Ahmed H. Zedan, Kamil Kuc,Pawel Wiechno,Brigitte Laguerre,Enrique Gonzalez-Billalabeitia, Mikhail Osipov, Didem Sener Dede,Jeffrey Goh,Gedske Daugaard, Pengfei Zhu,Kentaro Imai,Yingjie Liu,Jose Angel Arranz Arija

Journal of Clinical Oncology（2024）

Cited 0|Views4

Key words

283-2494-5577-2829-12292,283-2494-5577-2829-12292,298-145-222-184-4809-5347,298-145-222-184-4809-11811,613-135-2370-7650-11339,613-135-2370-7650-2700,261-566-148,613-135-244-3829-325,4327,242,4327,242,256,38092-25779,38092-34311,38092-29187,38116-38094-8

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined